Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.0748 $0.0748 Friday, 10th May 2024 BLCM stock ended at $0.0748. During the day the stock fluctuated 0% from a day low at $0.0748 to a day high of $0.0748.
90 days $0.0701 $0.104
52 weeks $0.0600 $0.85

Historical Bellicum Pharmaceuticals prices

Date Open High Low Close Volume
Nov 28, 2016 $20.52 $20.52 $18.68 $18.85 317 095
Nov 25, 2016 $20.78 $20.78 $20.17 $20.65 81 371
Nov 23, 2016 $20.39 $20.77 $19.11 $20.63 348 997
Nov 22, 2016 $22.90 $22.94 $20.73 $20.93 268 622
Nov 21, 2016 $22.59 $22.89 $22.08 $22.80 296 889
Nov 18, 2016 $22.06 $22.99 $22.06 $22.52 221 823
Nov 17, 2016 $21.07 $22.41 $21.04 $22.03 258 526
Nov 16, 2016 $22.06 $22.97 $21.59 $21.95 391 303
Nov 15, 2016 $22.57 $22.81 $21.73 $22.32 520 303
Nov 14, 2016 $22.24 $23.11 $21.90 $22.69 663 639
Nov 11, 2016 $20.68 $22.25 $20.10 $22.14 438 113
Nov 10, 2016 $19.23 $20.95 $19.13 $20.49 558 317
Nov 09, 2016 $18.48 $19.98 $18.38 $19.28 608 190
Nov 08, 2016 $17.50 $18.15 $17.29 $17.73 245 893
Nov 07, 2016 $17.25 $17.92 $17.04 $17.75 176 500
Nov 04, 2016 $16.34 $17.11 $16.34 $16.72 234 000
Nov 03, 2016 $16.44 $17.08 $16.11 $16.31 260 000
Nov 02, 2016 $17.00 $17.18 $16.09 $16.35 248 100
Nov 01, 2016 $16.58 $17.40 $16.41 $16.88 194 300
Oct 31, 2016 $16.49 $16.77 $16.10 $16.56 177 500
Oct 28, 2016 $16.65 $16.94 $16.00 $16.47 214 000
Oct 27, 2016 $17.50 $17.74 $16.76 $16.82 215 500
Oct 26, 2016 $17.14 $17.60 $17.04 $17.37 179 300
Oct 25, 2016 $16.98 $17.29 $16.68 $17.14 148 800
Oct 24, 2016 $17.11 $17.11 $16.64 $16.93 170 500
Click to get the best stock tips daily for free!

About Bellicum Pharmaceuticals

Bellicum Pharmaceuticals Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem ce... BLCM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT